Solaris Endovascular today announced its formation to develop solutions for dialysis access and treating peripheral artery ...
A “bioadaptive” stent might circumvent the slow accumulation of target lesion failure that has been a consistent weakness of ...
Mater Private Network has opened its new, state-of-the-art Cardiac Catheterisation Laboratory (Cath Lab) at its Eccles Street Hospital, representing a significant €8m investment in its cardiovascular ...
Routine use of an orbital atherectomy device to remove calcium from severely blocked coronary arteries before patients ...
The RESTO (Morphological Parameters of In‐Stent ... cardiac causes, target‐vessel myocardial infarction, or ischemia‐driven target‐vessel revascularization) was assessed. The study included 297 ...
Plus, news about Interius BioTherapeutics, Hope Medicine, PMV Pharmaceuticals, Epitopea, Alyssum Therapeutics and a new dementia trial accelerator in ...
This targeted drug therapy is designed to mimic human antibodies and inhibit the activity of ENPP1, which Deb had previously established increases in the aftermath of a heart attack. The ...
Persistent atrial fibrillation (AFib) is a condition where an irregular heart rhythm lasts for more ... following the use of anti-arrhythmic drug (AAD) therapy, which is commonly prescribed ...
Pakistan has commenced the commercial export of cardiac stents ... Besides Bare Metal Stents (BMS), the facility also has the capacity to manufacture Drug Eluting Stents (DES) and Percutaneous ...
A University of Alberta pharmacology researcher has discovered that a new experimental anti-obesity drug improves diastolic heart function in mice with type 2 diabetes independent of its weight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback